IUBMB Focused Meeting on Integrative Omics of Nuclear Function
Avra Imperial Hotel, Kolymvari 73006, Chania, Crete, Greece T. +30 28240 84500
Web Address
https://www.nuclearomics2023.org/
Registration
Deadline: 15/09/2023
Click here to register
General Information
Recent insights from quantitative single-cell and single-molecule approaches have led to the realization that cell-to-cell variability, the stochastic nature of molecular events and physical phenomena such as phase separation, are central to chromatin biology. As the complexity of nuclear processes is becoming more apparent, there is a growing need for the integration of data from the different techniques to study them. Therefore, the scope of the IUBMB Focused Meeting on Integrative Omics of Nuclear Function is to provide a wider perspective of how advanced genomic, proteomic, and imaging approaches can be combined to investigate nuclear structure and function, by fostering exchange between scientists employing diverse experimental and computational approaches to investigate different aspects of chromatin biology to integrate and visualize protein and DNA networks to better understand nuclear processes. The scientific program includes lectures by leaders and up-and-coming talents, organized in 10 scientific sessions and 3 Keynote Lectures, with a total of 32 invited speakers. Junior scientists can present their work in selected short oral presentations, in two poster sessions and “poster flash talks”. The program includes a “problem solving” session, Women in Science and Science in Society Lectures and a Round Table to conclude the meeting.
Deadline for submissions: 31/08/2023
Meeting organisers:
info@nuclearomics2023.org
Speakers:
Company of Biologists Keynote Speaker: Genevieve Almouzni, Institut Curie, Paris, France
EMBO Keynote Speaker: Ana Pombo, Max-Delbrück Centre for Molecular Medicine, Berlin
EMBO Science Policy Keynote Speaker: Wendy Bickmore, University of Edinburgh, UK
EMBO YIP Speaker: Tuncay Baubec, Utrecht University, Netherlands
EMBO YIP Speaker: Tineke Lenstra, Netherlands Cancer Institute, Amsterdam, Netherlands
